This inventor holds 1 USPTO granted patent. Top assignee: Schering Corporation. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Thomas B Schall: Innovator in Cytokine Research
Introduction
Thomas B Schall is a notable inventor based in Menlo Park, CA (US). He has made significant contributions to the field of immunology, particularly in the development of cytokine antibodies. His work has implications for understanding and treating various diseases.
Latest Patents
Thomas B Schall holds 1 patent for his invention titled "Anti-mammalian CX3C cytokine antibodies." This patent describes nucleic acids encoding a new family of chemokines, the CX3C family, derived from mammals. The patent also includes reagents related to these chemokines, such as specific antibodies and purified proteins. Additionally, it outlines methods for using these reagents and related diagnostic kits.
Career Highlights
Throughout his career, Thomas has been associated with Schering Corporation, where he has focused on advancing research in cytokine biology. His innovative work has contributed to the understanding of immune responses and potential therapeutic applications.
Collaborations
Thomas has collaborated with notable colleagues, including Kevin B Bacon and Fernando J Bazan. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.
Conclusion
Thomas B Schall's contributions to cytokine research and his patented innovations highlight his role as a significant figure in the field of immunology. His work continues to influence the development of diagnostic and therapeutic tools.